Literature DB >> 28368734

The Relationship Between Psychosocial Adjustment and Coping Strategies Among Patients With Multiple Sclerosis in Turkey.

Ayse Okanli1, Derya Tanriverdi2, Gülay Ipek Coban3, Sibel Asi Karakaş4.   

Abstract

BACKGROUND: Multiple sclerosis (MS) is a disease with significant psychosocial adjustment challenges.
OBJECTIVE: The objective of the study was to assess the psychosocial adjustment and coping strategies in patients with MS and to put forth the relationships between them.
DESIGN: The sample group comprised 85 outpatients with MS who were admitted to the Neurology Clinic of a university hospital for treatment between October 2007 and July 2008. Data were acquired via an information form and the Psychosocial Adjustment to Illness Scale and Coping Strategy Indicator.
RESULTS: It was determined that 55% of the patients had poor psychosocial adjustment levels. Statistically significant relationship was found between Psychosocial Adjustment to Illness Scale-Self-Report and problem solving as well as seeking social support coping strategies ( p < .01). Psychosocial adjustment got worse with decreasing problem-solving and seeking-social support coping strategies of patients.
CONCLUSIONS: The psychosocial adjustment to MS of patients is closely related with effective coping strategies. The results have emphasized the significant role of mental health and social services and coping strategies regarding the comprehensive care needs of these patients.

Entities:  

Keywords:  MS; coping strategy; multiple sclerosis; psychosocial adjustment

Mesh:

Year:  2016        PMID: 28368734     DOI: 10.1177/1078390316680027

Source DB:  PubMed          Journal:  J Am Psychiatr Nurses Assoc        ISSN: 1078-3903            Impact factor:   2.385


  1 in total

1.  Changes in disability in people with multiple sclerosis: a 10-year prospective study.

Authors:  David Conradsson; Charlotte Ytterberg; Lena von Koch; Sverker Johansson
Journal:  J Neurol       Date:  2017-11-20       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.